Two randomized migraine studies of galcanezumab: Effects on patient functioning and disability

OBJECTIVE: To evaluate changes from baseline in patient-reported outcomes for measures of functioning and disability among patients with migraine treated with galcanezumab or placebo. METHODS: Patients with episodic migraine (4–14 monthly migraine headache days) were treated with either galcanezumab...

Descripción completa

Detalles Bibliográficos
Autores principales: Ford, Janet H., Ayer, David W., Zhang, Qi, Carter, Jeffrey N., Leroux, Elizabeth, Skljarevski, Vladimir, Aurora, Sheena K., Tockhorn-Heidenreich, Antje, Lipton, Richard B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6693431/
https://www.ncbi.nlm.nih.gov/pubmed/31270220
http://dx.doi.org/10.1212/WNL.0000000000007856

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6693431/
https://www.ncbi.nlm.nih.gov/pubmed/31270220
http://dx.doi.org/10.1212/WNL.0000000000007856

Ejemplares similares